FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 361:522-523 July 30, 2009 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Dondorp, A. M. Related Article by Roestenberg, M. PubMed Citation

Over the past 5 years, we have witnessed remarkable progress in malaria control. In Africa, the approach has been to "scale up for impact"¹ by rapidly deploying insecticide-treated nets and providing artemisinin-based combination therapy. Programs in Equatorial Guinea, Ethiopia, Rwanda, Zambia, and Zanzibar have shown that when coverage of these interventions exceeds 50 to 60% of the population, the prevalence of infection with malaria parasites and mortality among children from such infection falls by 20 to 25% within 12 to 36 months.²

Progress has been based on highly effective and affordable malaria-control tools and mobilization of substantial funding at the . . . [Full Text of this Article]

Source Information

From the Malaria Control Program, Program for Appropriate Technology in Health (PATH), Seattle.

Related Letters:

Artemisinin-Resistant Malaria in Asia
Noedl H., Socheat D., Satimai W.
Extract | Full Text | PDF  
N Engl J Med 2009; 361:540-541, Jul 30, 2009. Correspondence

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2010 Massachusetts Medical Society. All rights reserved.